The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
GAIN-(C): Efficacy and safety analysis of imgatuzumab (GA201), a novel dual-acting monoclonal antibody (mAb) designed to enhance antibody-dependent cellular cytotoxicity (ADCC), in combination with FOLFIRI compared to cetuximab plus FOLFIRI in second-line KRAS exon 2 wild type (e2WT) or with FOLFIRI alone in mutated (e2MT) metastatic colorectal cancer (mCRC).
 
John A. Bridgewater
Consulting or Advisory Role - Merck; Roche; Sanofi
Travel, Accommodations, Expenses - Merck
 
Andres Cervantes
Honoraria - Roche
Research Funding - Roche (Inst)
 
Ben Markman
Honoraria - Roche
 
Salvatore Siena
Stock and Other Ownership Interests - Ignyta
Honoraria - Amgen; Bayer
Consulting or Advisory Role - Amgen; Bayer; Ignyta; Roche/Genentech; Sanofi
Speakers' Bureau - Amgen; Bayer
Research Funding - Bayer (Inst)
Patents, Royalties, Other Intellectual Property - Amgen
Travel, Accommodations, Expenses - Amgen; Bayer; Roche
 
Antonio Cubillo
No Relationships to Disclose
 
Rocio Garcia Carbonero
Honoraria - Boehringer Ingelheim (I); Lilly (I); Pfizer (I); Roche (I)
Consulting or Advisory Role - Boehringer Ingelheim (I); Lilly (I); Pfizer (I); Roche (I)
Travel, Accommodations, Expenses - Amgen; Boehringer Ingelheim (I); Ipsen; Lilly (I); Merck; Roche (I)
 
Darren Sigal
Speakers' Bureau - Lilly; Novartis; Pfizer
 
Giuseppe Aprile
Consulting or Advisory Role - Amgen; Lilly; Merck; Roche; Sanofi
Speakers' Bureau - Amgen; Lilly; Merck; Roche; Sanofi
 
David Cunningham
Research Funding - Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); Merck Serono (Inst); Novartis (Inst); Roche (Inst); Sanofi (Inst)
 
Cristina Nadal
Patents, Royalties, Other Intellectual Property - Memorial Sloan-Kettering Cancer Center
 
Carles Pericay
No Relationships to Disclose
 
Leslie M. Samuel
Honoraria - Amgen; Merck Serono; Sanofi
Research Funding - Bayer; Merck Serono (Inst); Roche (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Roche
 
Daniel Hochhauser
Employment - Totally Health
Research Funding - AstraZeneca (Inst); Merck Serono (Inst)
 
Jose Alejandro Perez-Fidalgo
No Relationships to Disclose
 
Andrew Strickland
No Relationships to Disclose
 
Cecile Guizani
Employment - Novartis (I); Roche
Stock and Other Ownership Interests - Roche
 
Sophie Golding
Employment - Roche; Roche (I)
Stock and Other Ownership Interests - Roche; Roche (I)
 
Vanesa Lopez Valverde
Employment - Roche
 
Marion Gabriele Ott
Employment - Roche
Leadership - Roche
 
Josep Tabernero
Consulting or Advisory Role - Amgen; Celgene; Chugai Pharma; ImClone Systems; Lilly; Merck KGaA; Millennium; Novartis; Roche/Genentech; Sanofi; Taiho Pharmaceutical